Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Delayed-Type Hypersensitivity Pathway (DTH)
- Target
- DTH
- Molecular classification
- Signaling Pathway, Immune Pathway
01
Overview
Delayed-type hypersensitivity (DTH), also known as Type IV hypersensitivity, is a cell-mediated immune response that typically develops 24 to 72 hours after exposure to an antigen recognized as foreign by the immune system. It is primarily mediated by T cells (CD4+ and CD8+), macrophages, and cytokines, leading to inflammation and tissue damage at the site of antigen exposure. DTH plays a role in defense against intracellular pathogens but can also contribute to autoimmune diseases and allergic conditions.
- Other names
- Type IV Hypersensitivity
02
Mechanism of action
Modulation of T cell activity and cytokine production; suppression of inflammatory responses.
03
Biological functions
Adaptive ImmunityCell-mediated ImmunityInflammationDefense against intracellular pathogens
04
Disease associations
Autoimmune DiseasesAllergic ReactionsInfectionInflammation
05
Safety considerations
ImmunosuppressionIncreased risk of infectionExacerbation of certain conditions upon immune modulation
06
Interacting drugs
Immunosuppressants
1 more in the full profile.
Beyond the preview
Go deeper on Delayed-Type Hypersensitivity Pathway (DTH).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Delayed-Type Hypersensitivity Pathway (DTH).